Biontech SE SEC Filings

What Biontech SE has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

BNTX overview →

Filings on file

since Sep 9, 2019

Warning signs

none filed

Last results

—

8-K item 2.02

Industry

Biological Products, (No Diagnostic Substances)

SIC 2836

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

Filed	What it reports	Form	Document
Oct 21, 2025	Tender offer SC TO-T	SC TO-T	Read ↗

Source: Biontech SE's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on BNTX

Company overviewEverything on BNTX in one place, with the price.Insider tradingWhat BNTX's own officers and directors buy and sell.Who owns itEvery manager reporting a position in BNTX.Funds holding itWhich funds and ETFs hold BNTX, and how big a bet.PatentsWhat BNTX is filing at the patent office.

Related datasets

PeopleCEOs, investors, public officials and market commentators.Insider TradingWhat company officers and directors buy and sell.Insider BuyingCluster buys, and chief executives buying their own stock.The InsidersOne page per filer: every company they file against.